Literature DB >> 25185134

Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation.

T Michael De Silva1, Mary L Modrick1, Pimonrat Ketsawatsomkron1, Cynthia Lynch1, Yi Chu1, Christopher J Pelham1, Curt D Sigmund1, Frank M Faraci1.   

Abstract

Although peroxisome proliferator-activated receptor-γ (PPARγ) is thought to play a protective role in the vasculature, its cell-specific effect, particularly in resistance vessels, is poorly defined. Nitric oxide (NO) plays a major role in vascular biology in the brain. We examined the hypothesis that selective interference with PPARγ in vascular muscle would impair NO-dependent responses and augment vasoconstrictor responses in the cerebral circulation. We studied mice expressing a dominant negative mutation in human PPARγ (P467L) under the control of the smooth muscle myosin heavy chain promoter (S-P467L). In S-P467L mice, dilator responses to exogenously applied or endogenously produced NO were greatly impaired in cerebral arteries in vitro and in small cerebral arterioles in vivo. Select NO-independent responses, including vasodilation to low concentrations of potassium, were also impaired in S-P467L mice. In contrast, increased expression of wild-type PPARγ in smooth muscle had little effect on vasomotor responses. Mechanisms underlying impairment of both NO-dependent and NO-independent vasodilator responses after interference with PPARγ involved Rho kinase with no apparent contribution by oxidative stress-related mechanisms. These findings support the concept that via effects on Rho kinase-dependent signaling, PPARγ in vascular muscle is a major determinant of vascular tone in resistance vessels and, in particular, NO-mediated signaling in cerebral arteries and brain microvessels. Considering the importance of NO and Rho kinase, these findings have implications for regulation of cerebral blood flow and the pathogenesis of large and small vessel disease in brain.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  cerebral arteries; microcirculation; nitric oxide; small vessel disease

Mesh:

Substances:

Year:  2014        PMID: 25185134      PMCID: PMC4192060          DOI: 10.1161/HYPERTENSIONAHA.114.03935

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  33 in total

Review 1.  Potassium channels and neurovascular coupling.

Authors:  Kathryn M Dunn; Mark T Nelson
Journal:  Circ J       Date:  2010-03-16       Impact factor: 2.993

Review 2.  Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.

Authors:  Klaudia Budzyn; Philip D Marley; Christopher G Sobey
Journal:  Trends Pharmacol Sci       Date:  2005-12-27       Impact factor: 14.819

Review 3.  The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).

Authors:  Marjorie A Peraza; Andrew D Burdick; Holly E Marin; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2005-12-01       Impact factor: 4.849

Review 4.  Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.

Authors:  Naoki Sawada; James K Liao
Journal:  Antioxid Redox Signal       Date:  2013-09-24       Impact factor: 8.401

5.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

6.  Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.

Authors:  C G Sobey; F M Faraci
Journal:  Stroke       Date:  1997-04       Impact factor: 7.914

Review 7.  Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling.

Authors:  Bryan T Richardson; Christopher F Dibble; Asya L Borikova; Gary L Johnson
Journal:  Biol Chem       Date:  2013-01       Impact factor: 3.915

8.  Selective cerebral vascular dysfunction in Mn-SOD-deficient mice.

Authors:  F M Faraci; M L Modrick; C M Lynch; L A Didion; P E Fegan; S P Didion
Journal:  J Appl Physiol (1985)       Date:  2006-03-02

9.  PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice.

Authors:  Michael J Ryan; Sean P Didion; Satya Mathur; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2004-01-26       Impact factor: 10.190

10.  Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells.

Authors:  Jeffrey D Alexis; Nadan Wang; Wenyi Che; Nicole Lerner-Marmarosh; Abha Sahni; Vyacheslav A Korshunov; Yiping Zou; Bo Ding; Chen Yan; Bradford C Berk; Jun-Ichi Abe
Journal:  Circ Res       Date:  2008-11-20       Impact factor: 17.367

View more
  18 in total

1.  Heterogeneous Impact of ROCK2 on Carotid and Cerebrovascular Function.

Authors:  T Michael De Silva; Dale A Kinzenbaw; Mary L Modrick; Lindsey D Reinhardt; Frank M Faraci
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

2.  Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging.

Authors:  T Michael De Silva; Ying Li; Dale A Kinzenbaw; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

Review 3.  Contributions of Aging to Cerebral Small Vessel Disease.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Annu Rev Physiol       Date:  2019-10-16       Impact factor: 19.318

Review 4.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 5.  Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma.

Authors:  Pimonrat Ketsawatsomkron; Curt D Sigmund
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-03       Impact factor: 2.894

Review 6.  Microvascular Dysfunction and Cognitive Impairment.

Authors:  T Michael De Silva; Frank M Faraci
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

7.  Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.

Authors:  Larry N Agbor; Anand R Nair; Jing Wu; Ko-Ting Lu; Deborah R Davis; Henry L Keen; Frederick W Quelle; James A McCormick; Jeffrey D Singer; Curt D Sigmund
Journal:  JCI Insight       Date:  2019-06-11

Review 8.  PPARγ Regulation in Hypertension and Metabolic Syndrome.

Authors:  Madeliene Stump; Masashi Mukohda; Chunyan Hu; Curt D Sigmund
Journal:  Curr Hypertens Rep       Date:  2015-12       Impact factor: 5.369

9.  Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.

Authors:  David M Hasan; Robert M Starke; He Gu; Katina Wilson; Yi Chu; Nohra Chalouhi; Donald D Heistad; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2015-04-27       Impact factor: 10.190

10.  Interference With Endothelial PPAR (Peroxisome Proliferator-Activated Receptor)-γ Causes Accelerated Cerebral Vascular Dysfunction in Response to Endogenous Renin-Angiotensin System Activation.

Authors:  Anand R Nair; Larry N Agbor; Masashi Mukohda; Xuebo Liu; Chunyan Hu; Jing Wu; Curt D Sigmund
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.